EXCIVA
exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been formulated for developing symptomatic and disease-modifying treatments, therapies, cures, prophylactics, supplements, formulations and methods of making and using such compositions, enabling the healthcare industry to access their program for rescuing and reusing approved drugs for new indications and new uses.
EXCIVA
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.exciva.com
Total Employee:
1+
Status:
Active
Total Funding:
10.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Font Awesome Apache Mobile Non Scaleable Content Euro Microsoft Exchange Online Office 365 Mail
Current Advisors List
Current Employees Featured
Founder
Investors List
Andera Partners
Andera Partners investment in Series A - Exciva
LBBW VC
LBBW VC investment in Series A - Exciva
Cure8 Ventures
Cure8 Ventures investment in Series A - Exciva
Andera Partners
Andera Partners investment in Seed Round - Exciva
Official Site Inspections
http://www.exciva.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Exciva"
About us | Exciva Gmbh
Established in 2016 in Heidelberg (Germany), EXCIVA is a privately held biotech company focused on developing clinical stage therapeutics for various indications in neuropsychiatry. …See details»
Exciva - Crunchbase Company Profile & Funding
Exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been …See details»
Exciva Company Profile 2024: Valuation, Funding & Investors
When was Exciva founded? Exciva was founded in 2016. Where is Exciva headquartered? Exciva is headquartered in Heidelberg, Germany. What is the size of Exciva? Exciva has 6 total …See details»
EXCIVA GmbH - LinkedIn
EXCIVA GmbH TARGETED DRUG RESCUE (TDR) There are about 3,000 drugs that have been approved by at least one country in this world. Just a handful of drugs received approval prior …See details»
EXCIVA GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EXCIVA GmbH of Heidelberg, Baden-Württemberg. Get the latest business insights from Dun & …See details»
News | Exciva Gmbh
Apr 1, 2024 The US PTO granted a patent to Exciva for its invention of innovative composition of matter with various therapeutic uses in neuropsychiatry October 11, 2022. Exciva successfully …See details»
Exciva GmbH - life-sciences-europe.com
More documents for Exciva GmbH [1] Exciva GmbH. (10/26/21). "Press Release: Exciva Raises €9 Million in Series A Round Led by Andera Partners". Heidelberg.... To subscribe to our free, …See details»
Exciva Company Profile - Office Locations, Competitors, Revenue
Exciva is a biopharmaceutical company delivering treatment to address symptoms of Alzheimer’s patients. It offers a product Deraphan that treats behavioral and psychological symptoms in …See details»
Exciva - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 26, 2021: Series A - Exciva …See details»
Exciva - Products, Competitors, Financials, Employees, …
Exciva is a biopharmaceutical company focused on developing therapies for neuropsychiatric symptoms of dementia, including Alzheimer's disease. The company's main objective is to …See details»
German-based startup attracts venture funding to address …
Nov 2, 2021 The Exciva team combines the best research and development expertise in the CNS field. Each member has a successful background in the pharma industry. “The caliber of …See details»
Exciva - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Exciva . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Exciva Raises €9M in Series A Funding - FinSMEs
Oct 26, 2021 Exciva GmbH, a Heidelberg, Germany-based clinical biotech company developing a novel therapeutic compound for treating agitation/aggression in Alzheimer’s disease, closed …See details»
Our science | Exciva Gmbh
Exciva's lead project is built upon two innovative drug development approaches targeting the symptomatic management of Alzheimer’s disease dementia that have recently emerged after …See details»
Exciva raises €9 million in Series A round led by Andera Partners
Oct 26, 2021 Heidelberg, Germany, October 26 – Exciva GmbH, a clinical biotech company developing a novel therapeutic compound for treating agitation/aggression in Alzheimer’s …See details»
Exciva GmbH | Expanded Access Navigator
Exciva is currently developing an investigational product (EXV-802) for potential treatment for agitation in people with Alzheimer’s Disease. Exciva understands that there may be individuals …See details»
Deraphan® Exciva GmbH - [LSE] Life-Sciences-Europe.com - The …
The Exciva team combines the best research and development expertise in the CNS field. Each member has a successful background in the pharma industry. “The caliber of the team and its …See details»
€9 million to address ‘Agitation/Aggression’ in Alzheimer’s
Oct 28, 2021 Exciva has closed a Series A financing of €9 million, led by Andera Partners, to develop the lead compound up to completion of Phase I. The product has the potential to treat …See details»
News | Exciva Gmbh
November 4, 2024. Our lead program, EXV-802 for the treatment of agitation in dementia associated with Alzheimer’s disease, received a Fast Track designation from the US FDA. …See details»